12-116575925-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_001085481.3(MAP1LC3B2):c.-18G>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.672 in 1,613,678 control chromosomes in the GnomAD database, including 373,536 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.62 ( 30499 hom., cov: 33)
Exomes 𝑓: 0.68 ( 343037 hom. )
Consequence
MAP1LC3B2
NM_001085481.3 5_prime_UTR
NM_001085481.3 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.642
Genes affected
MAP1LC3B2 (HGNC:34390): (microtubule associated protein 1 light chain 3 beta 2) Predicted to enable microtubule binding activity and ubiquitin protein ligase binding activity. Predicted to be involved in autophagy of mitochondrion; cellular response to nitrogen starvation; and macroautophagy. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 12-116575925-G-C is Benign according to our data. Variant chr12-116575925-G-C is described in ClinVar as [Benign]. Clinvar id is 2688029.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.699 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAP1LC3B2 | NM_001085481.3 | c.-18G>C | 5_prime_UTR_variant | 2/2 | ENST00000556529.4 | NP_001078950.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAP1LC3B2 | ENST00000556529.4 | c.-18G>C | 5_prime_UTR_variant | 2/2 | 3 | NM_001085481.3 | ENSP00000450524 | P1 |
Frequencies
GnomAD3 genomes AF: 0.624 AC: 94720AN: 151876Hom.: 30502 Cov.: 33
GnomAD3 genomes
AF:
AC:
94720
AN:
151876
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.595 AC: 149167AN: 250672Hom.: 47415 AF XY: 0.605 AC XY: 82032AN XY: 135684
GnomAD3 exomes
AF:
AC:
149167
AN:
250672
Hom.:
AF XY:
AC XY:
82032
AN XY:
135684
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.678 AC: 990438AN: 1461682Hom.: 343037 Cov.: 70 AF XY: 0.675 AC XY: 490588AN XY: 727154
GnomAD4 exome
AF:
AC:
990438
AN:
1461682
Hom.:
Cov.:
70
AF XY:
AC XY:
490588
AN XY:
727154
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.623 AC: 94751AN: 151996Hom.: 30499 Cov.: 33 AF XY: 0.614 AC XY: 45616AN XY: 74288
GnomAD4 genome
AF:
AC:
94751
AN:
151996
Hom.:
Cov.:
33
AF XY:
AC XY:
45616
AN XY:
74288
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1547
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 67% of patients studied by a panel of primary immunodeficiencies. Number of patients: 64. Only high quality variants are reported. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at